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derived peptides in adipogenesis. Immunocytochemical
analysis of 3T3-L1 adipocyte cells showed stronger
preproghrelin expression compared with that observed in
3T3-L1 preadipocyte cells. Insulin promoted this
expression throughout adipogenesis identifying mTORC1
as a critical downstream substrate for this profile. The
role of preproghrelin-derived peptides on the differentiation
process was supported by preproghrelin knockdown
experiments, which revealed its contribution to adipogen-
esis. Neutralization of endogenous O-acyl ghrelin (acylated
ghrelin), unacylated ghrelin, and obestatin by specific
antibodies supported their adipogenic potential. Furthermore,
a parallel increase in the expression of ghrelin-associatedJournal of Endocrinology (2011) 210, R1–R7
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(PC1/3) and membrane-bound O-acyltransferase 4
(MBOAT4), was dependent on the expression of preproghre-
lin in the course of insulin-induced adipogenesis.
The coexpression of preproghrelin system and their
receptors, GHSR1a and GPR39, during adipogenesis
supports an autocrine/paracrine role for these peptides.
Preproghrelin, PC1/3, and MBOAT4 exhibited dissimilar
expression depending on the white fat depot, revealing
their regulation in a positive energy balance situation in
mice. The results underscore a key role for preproghrelin-
derived peptides on adipogenesis through an autocrine/
paracrine mechanism.
Journal of Endocrinology (2011) 210, R1–R7Introduction
The concept of adipose tissue as an endocrine organ redefined
the understanding of the mechanisms by which adipocytes
affect whole-body energy homeostasis (Scherer et al. 2006,
Trujillo et al. 2006). Adipose cells not only serve as inert
storage compartments for triglycerides but also synthesize and
secrete a variety of peptide and nonpeptide factors. These
factors allow communication among the adipose tissue with
other organs as well as inside the adipose tissue. This cross
talk coordinates a variety of biological processes including
energy metabolism, neuroendocrine function, and immune
function (Scherer et al. 2006, Virtue & Vidal-Puig 2010).Added to this capacity, adipose tissue expresses a broad
spectrum of receptors that allow it to respond to signals
from hormone systems as well as from the central nervous
system. Although regulation of adipocyte homeostasis by
endocrine factors has been extensively studied, the local
regulation of lipid accumulation and adipogenesis by auto/
paracrine factors remains relatively unstudied. Observations
that preproghrelin expression increased during adipogenesis
(Gurriaran-Rodriguez et al. 2010) prompted us to examine
the possible role for this peptide (Castañeda et al. 2010) as
source of potential auto/paracrine factors, acylated ghrelin
(AG), unacylated ghrelin (UAG), and obestatin, in the
regulation of adipogenesis.DOI: 10.1530/JOE-11-0233
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Peptides and reagents
AG and UAG were obtained from Global Peptide (Fort
Collins, CO, USA). Obestatin was obtained from California
Peptide Research (Napa, CA, USA). All other chemical
reagents were from Sigma.Cell culture and differentiation induction of 3T3-L1
preadipocytes
3T3-L1 preadipocytes were maintained in DMEM
containing 10% fetal bovine serum (FBS), 100 U/ml
penicillin, and 100 U/ml streptomycin. For differentiation
assays, group A was treated with 0.5 mM isobutylmethyl-
xanthine (IBMX) and 25 mM dexamethasone (DEX) in
DMEM containing 10% FBS for 3 days and then maintained
in DMEM supplemented with 10% FBS for 7 days. Group B
was treated with 0.5 mM IBMX, 25 mM DEX, and 861 nM
insulin in DMEM containing 10% FBS for 3 days and then
for 7 days with insulin (172 nM). Differentiation was assessed
by staining formalin-fixed adipocytes with Oil Red O
(Gurriaran-Rodriguez et al. 2010).Immunoblot analysis
The cells were lysed on ice-cold RIPA buffer (Tris–HCl (pH
7.2), 50 mM; NaCl, 150 mM; EDTA, 1 mM; NP-40, 1%
(v/v); Na-deoxycholate, 0.25% (w/v); protease inhibitor
cocktail (Sigma); phosphatase inhibitor cocktail (Sigma)),
clarified by centrifugation (14 000 g for 15 min at 4 8C), and
the protein concentration was quantified using the QuantiPro
BCA Assay Kit (Sigma). Cellular proteins were fractionated
by SDS–PAGE before immunoblotting against preproghrelin,
membrane-bound O-acyltransferase 4 (MBOAT4), prohor-
mone convertase 1/3 (PC1/3), GHSR1a, tubulin, ERK1/2,
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), actin or
GPR39 (Abcam, Cambridge, UK). Immunoreactive bands
were detected by ECL Plus Western Blotting Kit (GE,
Pittsburgh, PA, USA). Protein expression was analyzed using
ImageJ Software (National Institutes of Health, Bethesda,
MD, USA) and normalized for corresponding loading
controls (ERK1/2, actin, or tubulin).Quantitative real-time PCR
Total RNA was extracted using Trizol (Invitrogen) and
purified with DNA-free Kit (Applied Biosystems, Foster
City, CA, USA). Preproghrelin, MBOAT4 and PC1/3 gene
expression was quantified after reverse transcription using
High-capacity cDNA Reverse Transcription Kit (Applied
Biosystems). qRT-PCR was performed using an ABI PRISM
7300 HT Sequence Detection System with specific Taqman
probes (Applied Biosystems). All results were normalized
to levels of ACTB as a housekeeping gene.Journal of Endocrinology (2011) 210, R1–R7Immunocytochemistry/immunohistochemistry
Cell and white adipose tissue (WAT) samples were processed
using standard procedures (Gurriaran-Rodriguez et al. 2010).
Slides were consecutively incubated with 1) anti-preproghre-
lin, anti-MBOAT4, or anti-PC1/3 rabbit polyclonal antibody
(Santa Cruz Biotechnology) at a dilution of 1:100 in Dako
ChemMate antibody diluent (Dako, Glostrup, Denmark);
2) EnVision peroxidase rabbit (Dako, Carpinteria, CA, USA)
used as the detection system; 3) 3,3 0-diaminobenzidine
tetrahydrochloride (Dako Liquid DABCSubstrate-chromo-
gen system). Cell and tissue sections were faintly counter-
stained with Harris’ hematoxylin.Small-interfering RNA silencing of gene expression
Double-stranded small-interfering RNA (siRNA) duplexes
for preproghrelin were as follows (Santa Cruz
Biotechnology): 3 0-CAGAGAAAGGAAUCCAAGA-5 0,
3 0-CCUUCGAUGUUGGCAUCAA-5 0, 3 0-CUCUCCU-
ACCACUUUAAGA-5 0. A non-silencing RNA duplex was
used as a control for all siRNA experiments. GPR39-targeted
siRNAs (Ambion siRNA sequence numbers s89441, s89442,
s89443) were selected from Silencer Pre-designed sequences
from Applied Biosystems. 3T3-L1 cells were transfected
with Lipofectamine 2000 (Invitrogen), prior to induction of
adipocyte differentiation.Animals
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the Faculty Animal Committee at the
University of Santiago de Compostela and the experiments
were performed in agreement with the Rules of Laboratory
Animal Care and International Law on Animal Experi-
mentation and all efforts were made to minimize suffering.
Adult Swiss male mice (8 weeks old) were housed in air-
conditioned rooms (22–24 8C) under a 12 h light:12 h
darkness cycle and fed with standard diet (SD, control) or
high-fat diet (HFD) for 12 weeks (D12451, Research Diets,
Inc., New Brunswick, NJ, USA). Food intake and body
weight were measured weekly during the experimental phase.
Animals were killed by decapitation between 1000 and 1200 h
when they were 20 weeks old. Excised WAT, omental and
subcutaneous, were washed with ice-cold Krebs–Ringer–
HEPES buffer (HEPES (pH 7.4), 25 mM; NaCl, 125 mM;
KCl, 5 mM; MgSO4, 1.2 mM; CaCl2, 2 mM; KH2PO4,
2 mM; glucose, 6 mM). Tissue samples were directly lysed in
ice-cold RIPA buffer for immunoblot analysis.Data analysis
All data represent meanGS.E.M. Statistical analysis was carried
out by ANOVA, using ANOVA with Bonferroni post hoc test.
*,#P!0.05.www.endocrinology-journals.org
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Expression of preproghrelin, PC1/3, and MBOAT4 throughout
adipogenesis in 3T3-L1 cells
Preproghrelin, PC1/3, and MBOAT4 proteins were found to
predominate in 3T3-L1 adipocyte cells compared to
preadipocyte cells as indicated in Fig. 1A. To ascertain
whether insulin determines this pattern of expression,
mRNA and protein expression of preproghrelin, PC1/3,
and MBOAT4 were analyzed in insulin-induced adipogenesis
and compared to that with no insulin treatment (group B:
insulin, DEX and IBMX; and group A: DEX, IBMX).
Whereas the preproghrelin mRNA showed a maximum at
144 h in group A, insulin-stimulated group showed two peaks
of expression at 6 and 144 h being w1.7- and 1.5-fold higher
compared with the former (Fig. 1B). The PC1/3 mRNA




































































































Figure 1 (A) Immunocytochemical detection of preproghrelin, PC1/3, a
magnification 40!). (B) Preproghrelin, PC1/3, and MBOAT4 mRNA lev
ACTB and expressed as meanGS.E.M. (nZ6). (C) Western blot analysis o
protein levels were examined in group A (3T3-L1 preadipocyte cells mai
3 days with 0.5 mM IBMX, 25 mM DEX) and group B (3T3-L1 preadipo
(172 nM) for 7 days after induction for 3 days (0.5 mM IBMX, 25 mM D
protein expression in absence or presence of rapamycin. After pretreatm
maintained for 72 h in DMEM containing 10% FBS, 0.5 mM IBMX, 25
containing 10% FBS (standard medium, SM). For B–D, data are expressed
version of this figure available via http://dx.doi.org/10.1530/JOE-10-023
www.endocrinology-journals.orggroup A, although this pattern of expression was clearly
regulated under insulin treatment in group B with a maximal
display at 144 h (w3.5-fold). The MBOAT4 mRNA levels
increased 24 h after treatment to return to near basal levels
over 144 h in group A (Fig. 1B). By contrast, insulin
treatment inhibited MBOAT4 mRNA throughout adipogen-
esis to return to basal levels in terminal differentiation
(Fig. 1B). Results of immunoblot analysis (Fig. 1C) showed
that the preproghrelin protein level markedly increased at 6 h
(w4.5-fold) which was sustained along terminal differen-
tiation in group B. A similar temporal profile was observed for
PC1/3 protein showing two maximal expression levels
concomitant with the maximum of preproghrelin expression
(w2.5- and 2.0-fold at 6 and 144 h respectively), whereas
MBOAT4 protein was apparent within 24 h and increased in
abundance throughout adipogenesis reaching maximal values
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nd MBOAT4 in 3T3-L1 preadipocyte and adipocyte cells (objective
els in the course of adipogenesis. Data were normalized to levels of
f preproghrelin, PC1/3, and MBOAT4 in adipogenesis. mRNA or
ntained in DMEM containing 10% FBS for 7 days after treatment for
cyte cells maintained in DMEM containing 10% FBSCinsulin
EX, and 861 nM insulin)). (D) Preproghrelin, PC1/3, and MBOAT4
ent with rapamycin (25 nM, 2 h), 3T3-L1 preadipocyte cells were
mM DEX, 861 nM insulin (differentiation medium, DM), or DMEM
as meanGS.E.M. (nZ3). *P!0.05 versus control values. Full colour
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protein was not significantly affected in the absence of insulin
treatment (group A). To further explore the mechanism
involved in the control of protein translation, the effect of
rapamycin treatment (25 nM) was examined 2 h prior to
insulin-induced adipocyte differentiation. Inhibition of
mTORC1/S6K1 pathway significantly reduced the pre-
proghrelin, MBOAT4, and PC1/3 protein expression at 72 h
after insulin-activated adipogenesis (Fig. 1D). Rapamycin
treatment did not significantly alter the expression of analyzed
proteins in 3T3-L1 preadipocyte-treated controls.Auto/paracrine role of preproghrelin-derived peptides in
adipogenesis in 3T3-L1 cells
To define the auto/paracrine role of preproghrelin-derived
peptides in adipogenesis, the effect of preproghrelin siRNA





























































































































































Figure 2 (A) Effect of siRNA depletion of preproghrelin on adipogenesis.
of adipocyte differentiation (DMEM/10% FBS or DMEM/10% FBS with i
IBMX, 25 mM DEX, and 861 nM insulin). Equal amounts of protein in ea
and preproghrelin (Ai and ii) by western blotting. Lipid droplet accumu
staining (Aiii panel). (B) Autocrine/paracrine role of obestatin and ghrel
maintained in DMEM containing 10% FBS (group 1), 10% FBSCinsulin
(5 mg/ml; group 3), 10% FBSCinsulin (172 nM)Canti-obestatin Ab (5 m
anti-ghrelin Ab (5 mg/ml; group 5), 10% FBSCinsulin (172 nM)Canti-g
(172 nM)Canti-ghrelin Ab (5 mg/ml)CUAG (5 mg/ml; group 7) for 7 day
25 mM DEX, and 861 nM insulin for 3 days. For A and B, data are mean
GPR39 on obestatin-activated pAKT (S473; 100 nM, 5 min) in 3T3-L1 p
expressed as fold of their levels in control siRNA-transfected cells (Ci a
adipogenesis (Ciii panel). For A–C, data are meanGS.E.M. of three indep
version of this figure available via http://dx.doi.org/10.1530/JOE-10-023
Journal of Endocrinology (2011) 210, R1–R7prior to induction of adipogenesis with siRNA designed
against preproghrelin reduced target protein expression by
51G2% (Fig. 2A). The effect of preproghrelin deficiency
decreased MBOAT4 and PC1/3 with respect to siRNA
control (49G3 and 61G3% respectively; Fig. 2A). Oil Red O
staining revealed that preproghrelin knockdown significantly
reduced insulin-mediated adipogenesis by at least 30G1 and
50G5% for 3T3-L1 preadipocyte cells under treatment with
IBMX, DEX, and insulin for 3 days and then maintained in
DMEM containing 10% FBS or insulin for 7 days respectively
(Fig. 2A). Similar results were obtained by neutralization of
endogenous obestatin or UAG/AG using anti-obestatin
(5 mg/ml) or anti-ghrelin (5 mg/ml; antibody raised against a
peptide mapping within an internal region of ghrelin)
antibodies (Ab; Fig. 2B). The differentiation-associated lipid
accumulation was significantly reduced by anti-obestatin Ab
(25G4%). A larger effect was observed with anti-ghrelin Ab
(39G2%). These effects were reverted neutralizing the
primary antibody with its respective antigen peptide3T3-L1 preadipocytes
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3T3-L1 cells transfected with preproghrelin siRNA prior to induction
nsulin (172 nM) for 7 days after induction for 3 days under 0.5 mM
ch sample were used to assess the expression of MBOAT 4, PC1/3,
lation was analyzed by spectrophotometry at 520 nm by Oil red O
in/O-acyl ghrelin on adipogenesis. 3T3-L1 preadipocyte cells were
(172 nM; group 2), 10% FBSCinsulin (172 nM)Canti-obestatin Ab
g/ml)Cobestatin (5 mg/ml; group 4), 10% FBSCinsulin (172 nM)C
hrelin Ab (5 mg/ml)CAG (5 mg/ml; group 6) or 10% FBSCinsulin
s after induction of differentiation by treatment with 0.5 mM IBMX,
of three independent experiments. (C) Effect of siRNA depletion of
readipocyte cells. Expression of pAKT (S473) and GPR39 were
nd ii panel). Western blot analysis of GHSR1a and GPR39 in
endent experiments (*,#P!0.05 versus control values). Full colour
3.
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GHSR1a and GPR39 was further analyzed in group B. The
GHSR1a protein levels were concomitant with the maximum
of preproghrelin expression (w1.7- and 1.4-fold at 6 and
144 h respectively; Fig. 2Cii). The GPR39 levels showed a
more sustained expression throughout adipogenesis with two
maximal levels (w2.3- and 2.2-fold at 48 and 144 h
respectively; Fig. 2Cii). The effect of acute GPR39 deficiency
was determined by means of siRNA in 3T3-L1 preadipocyte
cells. The constructs decreased GPR39 expression by 44G2%
(Fig. 2Cii). Silencing of GPR39 in preadipocyte cells
decreased obestatin-activated AKT(S473) with respect to
siRNA control (55G4% under treatment with obestatin
(100 nM) for 5 min) in accordance with previous results
(Gurriaran-Rodriguez et al. 2010).Preproghrelin, PC1/3, and MBOAT4 expression in WAT
Preproghrelin, PC1/3, and MBOAT4 were detected immu-
nohistochemically in omental and subcutaneous WAT
obtained from mice under normal chow (control; Fig. 3A).
Immunoblot analysis comparing WAT obtained from mice
under normal chow and HFD showed that preproghrelin
expression was enhanced in subcutaneous WATof HFD mice
relative to WAT of control mice (w0.5-fold), although its
expression was not altered in omental WAT of HFD mice































































































































Figure 3 (A) Immunohistochemical analysis of preproghrelin,
PC1/3, and MBOAT4 in omental and subcutaneous WAT obtained
from control mice (objective magnification 20!). (B) Immunoblot
analysis of preproghrelin, PC1/3, and MBOAT4 in omental and
subcutaneous WAT obtained from control and HFD mice (nZ10
per group). Data are expressed as meanGS.E.M. *P!0.05
versus control values. Full colour version of this figure available
via http://dx.doi.org/10.1530/JOE-10-0233.
www.endocrinology-journals.orgsubcutaneous WAT of HFD mice (w1.5- and 0.6-fold
respectively). MBOAT4 levels were also augmented in both
omental and subcutaneous WAT of HFD mice (w0.8- and
0.4-fold respectively; Fig. 3B).Discussion
In this study, we have demonstrated that preproghrelin
plays a critical role in the process of adipogenesis. We have
shown that insulin-induced adipocyte conversion is
impaired in the absence of preproghrelin. Furthermore,
neutralization of preproghrelin-derived peptides displays
defective accumulation of lipid droplets. Thus, preprogh-
relin is a key source of autocrine peptides involved in
adipocyte differentiation. Furthermore, we have identified
that preproghrelin and the enzymatic machinery associated to
the processing of this peptide into UAG and AG are
upregulated during adipose conversion. This enzymatic
system includes PC1/3, which cleaves after arginine-28 of
proghrelin leading to the production of the mature 28 amino
acid peptide (Zhu et al. 2006) and MBOAT4, a polytopic
membrane-bound enzyme that attaches the octanoyl residue
to serine-3 in AG (Gutierrez et al. 2008, Yang et al. 2008). The
changes in mRNA and protein expression were further
associated with insulin action, although transcription and
translation of these targets showed different regulatory systems.
In addition, acute inhibition of mTORC1 activity in the
presence of rapamycin led to decreased levels of these proteins.
These data suggest the involvement of the mTORC1/S6K1
pathway in the regulation of preproghrelin, PC1/3, and
MBOAT4 translation during the early steps of adipogenesis.
This point disagree with the findings that inhibition of
mTORC1 stimulates gastric and pancreatic preproghrelin
expression (Xu et al. 2009, An et al. 2010). Indeed, it is
likely that the mTORC1/S6K1 pathway and preproghrelin
interact in a tissue-specific manner. In addition, the type of
pharmacological treatment, chronic versus acute, might also
explain this paradigm. In this sense, it is important to note
that chronic rapamycin treatment can inhibit both mTORC1
and mTORC2 activities (Sarbassov et al. 2006, Laplante &
Sabatini 2009).
The potential role of preproghrelin as source of auto/
paracrine peptides has remained unstudied in adipose tissue,
possibly as a result of the perception that preproghrelin is not
substantially expressed in this tissue. As reported here and
elsewhere (Gnanapavan et al. 2002, Knerr et al. 2006),
however, adipose tissue expresses relatively high levels of
preproghrelin. This peptide undergoes stepwise processing to
produce UAG, AG, and obestatin (Zhu et al. 2006). AG is
widely known for its role in adipogenesis and lipid storage in
WAT in both rodents (Wells 2009) and humans (Rodriguez
et al. 2009). It was recently reported that obestatin also
promotes adipogenesis, being a regulator of adipocyte
metabolism (Gurriaran-Rodriguez et al. 2010). By contrast,
the role of UAG in adipogenesis is not clear, because there areJournal of Endocrinology (2011) 210, R1–R7
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accumulation (Zhang et al. 2008, Delhanty et al. 2010),
whereas others showed that UAG increased adipogenesis and
lipid accumulation in both rodents (Thompson et al. 2004)
and human adipocytes (Rodriguez et al. 2009). In this study,
we found that the net effect of these secreted preproghrelin-
derived peptides favors adipocyte conversion. This fact
appears to be a consequence of the AKT activation by
both AG and obestatin in adipose tissue (Lodeiro et al.
2009, Gurriaran-Rodriguez et al. 2010). There is strong
evidence, including results obtained from genetic mouse
models, supporting the concept that AKT is a key node for
regulation of the transcriptional program required for
adipogenesis (Cho et al. 2001, Garofalo et al. 2003, Xu et al.
2004, Manning & Cantley 2007, Berggreen et al. 2009,
Zhang et al. 2009). Interestingly, knockdown experiments by
preproghrelin siRNA displayed defective adipocyte differen-
tiation. We propose that insulin activates preproghrelin
expression and consequent secretion of preproghrelin-derived
peptides, which intensify insulin signaling to AKT in an
autocrine manner in preadipocyte cells. The coexpression of
GHSR1a and GPR39 supports this autocrine function. These
peptides further determine the progressive expression of
PC1/3 and MBOAT4 related to adipocyte differentiation
defining the secretion rate between AG and UAG. Through a
paracrine action, preproghrelin-derived peptides impact on
adipocytes leading to AKT signaling favoring regulation
processes such as hypertrophy. Thus, it is likely that the insulin
effect is mediated by expression and secretion of these
peptides on the late stage of adipogenesis.
In agreement with our data obtained in vitro, where the
expression of preproghrelin, PC1/3, and MBOAT4 was
increased during adipogenesis, we found that, in both
omental and subcutaneous fat of mice fed on HFD, the
expression of these factors is higher than in the WATof mice
fed on SD. The only exception was the expression of
preproghrelin in omental fat that remained unchanged
between SD and HFD mice, indicating that preproghrelin is
regulated in a fat depot-specific manner. Overall, our findings
showing higher levels of preproghrelin-related factors in the
WATof animals where adipogenesis is stimulated suggest that
preproghrelin, PC1/3, and MBOAT4 might play an
important role in the accumulation of lipids during diet-
induced obesity.
In conclusion, we have shown that insulin triggers the
expression of preproghrelin, and have demonstrated that
preproghrelin is a critical target for insulin-induced adipo-
genesis. The mechanisms of regulation of these targets by
insulin await further investigation.Declaration of interest
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